The role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of advanced stage non-small cell lung cancer

The epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) like erlotinib and gefitinib have been extensively studied. Multiple randomized trials have evaluated the role of EGFR TKIs in advanced stage non-small cell lung cancer (NSCLC) as a monotherapy in the first line, or subseque...

Full description

Saved in:
Bibliographic Details
Main Authors: Voon, Pei-Jye, Chul Cho, Byoung, Yeo, Wee-Lee, Soo, Ross A
Format: Artigo
Language:Inglês
Published: Pioneer Bioscience Publishing Company 2010
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256457/
https://ncbi.nlm.nih.gov/pubmed/22263036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2010.02.03.6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items